NIHR reveals phase 1/2 trial to evaluate an investigational vaccine for mpox in the UK by Jen Brogan | Mar 15, 2024 | News | 0 More than 3,700 cases of mpox have been identified in the UK since May 2022 Read More
First UK patients receive experimental mRNA therapy for cancer in global trial by Jen Brogan | Feb 13, 2024 | News | 0 The phase 1/2 Mobilize trial is evaluating the safety and efficacy of mRNA-4359 Read More